Barclays »

Pharmacyte Biotech shares owned by Barclays

Quarter-by-quarter ownership of Pharmacyte Biotech (PMCB) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Pharmacyte Biotech

Tip: Access up to 7 years of quarterly data

All positions including Pharmacyte Biotech held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pharmacyte Biotech by Barclays

Quarter filed Position value Share count Share price at filing
2026-06-30 $147 192 0.77

More positions owned by Barclays

STATE STR SPDR S&ampP 500 ETF T Fund (SPY)
Ishares Tr Opt Call Option (EEM)
Microsoft Corp Opt Call Option (MSFT)
Invesco Qqq Tr Fund (QQQ)
Ishares Tr Fund (IWM)
Nvidia Corporation Opt Call Option (NVDA)
Micron Technology (MU)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Amazon Opt Put Option (AMZN)
Vaneck Etf Trust Opt Put Option (SMH)
Tesla Motors (TSLA)
Advanced Micro Devices Opt Put Option (AMD)
Broadcom Opt Put Option (AVGO)
Ishares Tr Opt Call Option (HYG)

View all positions for Barclays

Top funds holding Pharmacyte Biotech

Citadel Advisors
Geode Capital Management
Vanguard Capital Management
Susquehanna International
Renaissance Technologies
XTX Topco
Northern Trust
Jane Street
Schonfeld Strategic Advisors
Vanguard Fiduciary Trust
Equitec Proprietary Markets
Commonwealth Equity Services
Hrt Financial
Tower Research Capital
UBS Group

View all funds holding Pharmacyte Biotech